LANGLEY, BC – Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (Frankfurt: D2EP), pleased to announce the acceptance of, its first Shatter vaporizer cartridge, under the Phyto Extractions brand. This product line represents a category expansion at the OCS as it is a novel product, offering a convenient-use format to the fast-growing extracts segment of the Canadian adult-use marketplace.
Designed with two strain-specific varieties, Santa Cruz Haze and Jet Fuel, the Shatter vaporizer cartridge product line is a hydrocarbon extracted concentrate containing 3-5 % total cannabis-derived terpenes with 79-82% THC potency. Phyto’s iconic Shatter, sought after by retailers and consumers, is formulated and filled for convenient use in a CCELL® 510 thread 1g cartridge.
Donald Dinsmore, COO of Phyto, commented, “The Jet Fuel variety is derived from Powdered Donuts, a Jet Fuel Gelato and Orange Cookies hybrid, while Santa Cruz Haze is derived from Blue Dream. Both strains are BC grown and extracted, creating two unique and satisfying full spectrum experiences derived entirely from cannabis. The products are designed for newcomers to the cannabis market, providing an approachable concentrate for people who have yet to dab or lack the full expertise and equipment. Our innovative Shatter Cartridge will help bring customers along their cannabis journey, from flower to distillate vape, shatter vape, and eventually dabbables like shatter and live resin. There is nothing quite like this in the market, and we believe it addresses an underserved and compelling segment of a rapidly growing consumer base.”
The Shatter Cartridge is expected to launch in licensed adult-use retailers in Ontario this fall and next to British Columbia, Alberta, Saskatchewan, and Manitoba.
For the best experience, the Company recommends pairing its cartridges withCCELLL® compatible, low, or multi-temp batteries, such as the M3B model. Concentrates are best consumed at lower temperatures to optimize the flavour profile and effect of the strain.
This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect to the Controlled Drugs and Substances Dealer’s License; the changing regulations surrounding certain psychedelics and associated treatments; societal acceptance of psychedelic treatments; the ability of the Company to conduct testing, production, or sales of any compounds beyond cannabis; and the ability of the Company to work with partners such as medical doctors, pharmaceutical companies and pharmacies if it is permitted to conduct extraction research and develop psychedelic compounds. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) changes in regulations surrounding multiple controlled substances; and (iv) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
The Canadian Securities Exchange has not reviewed or approved of any contents of this news release.
(This information is primarily sourced from Adastra Holdings Ltd. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).